Transchem
TRANSCHEMLTD NSE
Transchem
HealthcareNSE: TRANSCHEMLTD BSE: 500422 Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹468 Cr
Volatility
High Risk
P/E Ratio
69.1
EBITDA
₹5.60 Cr
Return on Equity
5.14%
Debt to Equity
0
Book Value
₹68.28
EPS
₹4.1
52W High
₹384
52W Low
₹47.52
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
4- Stock is trading at 5.58 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.98% over last 3 years.
- Earnings include an other income of Rs.12.7 Cr.
Growth Rate
Revenue Growth
-16.96% lower than
3Y
Net Income Growth
-17.31% lower than
3Y
Cash Flow Change
-108% lower than
3Y
ROE
-22% lower than
3Y
ROCE
-24.63% lower than
3Y
EBITDA Margin (Avg.)
-4.2% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0.41 | 0 | 0 | 0.21 | 2.42 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.4 | 0.39 | 0.5 | 0.86 | 0.27 | 0.37 | 0.54 | 2.9 | 0.29 | 0.75 | 1.31 | 1.31 | 0.7 |
| Operating Profit | -0.4 | -0.39 | -0.5 | -0.45 | -0.27 | -0.37 | -0.33 | -0.48 | -0.29 | -0.75 | -1.31 | -1.31 | -0.7 |
| OPM % | — | — | — | -109.76% | — | — | -157.14% | -19.83% | — | — | — | — | — |
| Other Income | 1.53 | 1.69 | 2.02 | 2.16 | 2.47 | 2.31 | 2.19 | 1.56 | 1.64 | 1.68 | 2.25 | 3.7 | 5.11 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 |
| PBT | 1.13 | 1.3 | 1.52 | 1.71 | 2.2 | 1.94 | 1.86 | 1.08 | 1.35 | 0.93 | 0.94 | 2.39 | 4.35 |
| Tax % | 24.78% | 25.38% | 25.66% | 26.9% | 24.09% | 25.26% | 25.27% | 32.41% | 26.67% | 27.96% | 43.62% | 12.55% | 21.38% |
| Net Profit | 0.85 | 0.97 | 1.14 | 1.25 | 1.66 | 1.44 | 1.39 | 0.73 | 0.99 | 0.68 | 0.53 | 2.09 | 3.42 |
| EPS in Rs | 0.69 | 0.79 | 0.93 | 1.02 | 1.36 | 1.18 | 1.14 | 0.6 | 0.81 | 0.56 | 0.43 | 1.71 | 2.79 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | -0.05 | -0.2 | 0 | 0.34 | 2.63 | 0 | 0 |
| Expenses | 0.78 | 0.93 | 0.98 | 1.69 | 1.18 | 1.39 | 1.88 | 2.54 | 1.73 | 2.08 | 4.09 | 3.63 | 4.07 |
| Operating Profit | -0.78 | -0.93 | -0.98 | -1.69 | -1.18 | -1.39 | -1.93 | -2.74 | -1.73 | -1.74 | -1.46 | -3.63 | -4.07 |
| OPM % | — | — | — | — | — | — | — | — | — | -511.76% | -55.51% | — | — |
| Other Income | 2.09 | 1.97 | 1.78 | 2.11 | 2.75 | 2.76 | 26.82 | 6.66 | 4.24 | 7.4 | 8.53 | 9.25 | 12.74 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Depreciation | 1.07 | 1.02 | 1.02 | 0.97 | 0.8 | 0.57 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 |
| PBT | 0.24 | 0.02 | -0.22 | -0.55 | 0.77 | 0.8 | 24.77 | 3.91 | 2.5 | 5.65 | 7.06 | 5.61 | 8.61 |
| Tax % | 45.83% | -150% | 0% | 116.36% | 61.04% | 47.5% | 2.5% | 26.6% | 50.8% | 25.66% | 26.06% | 23.53% | — |
| Net Profit | 0.12 | 0.05 | -0.22 | -1.19 | 0.31 | 0.41 | 24.15 | 2.87 | 1.24 | 4.2 | 5.23 | 4.3 | 6.72 |
| EPS in Rs | 0.1 | 0.04 | -0.18 | -0.97 | 0.25 | 0.33 | 19.73 | 2.34 | 1.01 | 3.43 | 4.27 | 3.51 | 5.49 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 |
| Reserves | 26.11 | 26.15 | 25.75 | 24.57 | 25.74 | 24.53 | 50.7 | 54.06 | 53.6 | 63.41 | 67.08 | 71.34 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.22 | 0.23 | 0.17 | 0.17 | 0.39 | 0.3 | 0.48 | 0.51 | 0.39 | 0.66 | 0.4 | 4.15 |
| Total Liabilities | 38.57 | 38.62 | 38.16 | 36.98 | 38.37 | 37.07 | 63.42 | 66.81 | 66.23 | 76.31 | 79.72 | 87.73 |
| Fixed Assets | 8.4 | 7.42 | 6.4 | 5.43 | 4.27 | 3.7 | 0.11 | 0.1 | 0.09 | 0.09 | 0.05 | 0.02 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 27.5 | 28.01 | 29.79 | 10.21 | 5.93 | 3.69 | 8.69 | 8.82 | 8.23 | 8.91 | 2.04 | 1.97 |
| Other Assets | 2.67 | 3.19 | 1.97 | 21.34 | 28.17 | 29.68 | 54.62 | 57.89 | 57.91 | 67.31 | 77.63 | 85.74 |
| Total Assets | 38.57 | 38.62 | 38.16 | 36.98 | 38.37 | 37.07 | 63.42 | 66.81 | 66.23 | 76.31 | 79.72 | 87.73 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.94 | 1.08 | 0.55 | -19.79 | 10.34 | -0.63 | -27.72 | 21.91 | 1.22 | -39.31 | 36 | -2.89 |
| Investing | -1.21 | -0.26 | -1.51 | 19.78 | 5.73 | 0.67 | 23.06 | 0.6 | -0.94 | 5.12 | 6.02 | 1.65 |
| Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -0.27 | 0.83 | -0.95 | -0.01 | 16.07 | 0.04 | -4.66 | 22.51 | 0.28 | -34.18 | 42.02 | -1.24 |
| Free Cash Flow | 0.94 | 1.04 | 0.55 | -19.79 | 10.53 | -0.63 | -1.79 | 21.91 | 1.22 | -39.31 | 36.53 | -1.31 |
| CFO/OP | -121 | -116 | -56 | 1,165 | -897 | 0 | 1,401 | -853 | -132 | 2,182 | -2,618 | 47 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | — | — | — | — | — | 0 | 0 | — | 440 | 376 | — |
| Inventory Days | — | 35,770 | 32,485 | — | — | — | -511 | -274 | — | 0 | 0 | — |
| Days Payable | — | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | — | — | — | — | — | — | -511 | -274 | — | 440 | 376 | — |
| Working Capital Days | — | — | — | — | — | — | 3,11,418 | 42,705 | — | 71,422 | 4,856 | — |
| ROCE % | 0.63% | 0.05% | -0.58% | -1.47% | 1.63% | 2.03% | 4.61% | 4.22% | 3.5% | 7.99% | 9.11% | 6.9% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Transchem insights
28 extracted metrics + investor summaries across FY14–FY25.
Documents
1
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
14h - Transchem declares it is not a large corporate for FY2025-26; no mandatory debt-borrowing applicability. 14h - Transchem declares it is not a large corporate for FY2025-26; no mandatory debt-borrowing applicability.
3
Board Meeting Outcome for The Meeting Held On May 05, 2026, Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
5 May - Board approved FY26 audited results; net profit ₹429.51 lakh, and reappointed internal auditors for FY27. 5 May - Board approved FY26 audited results; net profit ₹429.51 lakh, and reappointed internal auditors for FY27.
5
Announcement under Regulation 30 (LODR)-Change in Management
5 May - Transchem reappointed M/s. L. T. Jadav & Co. as internal auditors for FY 2026-2027 on May 05, 2026. 5 May - Transchem reappointed M/s. L. T. Jadav & Co. as internal auditors for FY 2026-2027 on May 05, 2026.
Frequently Asked Questions about Transchem
What does Transchem Ltd do?
Transchem Ltd has transitioned from
mushroom manufacturing and exports
to financial services. After selling its non-operational Pune mushroom undertaking
in 2020, it primarily earned through inter-corporate deposits and treasury investments.[1][2]
Where is Transchem Ltd (500422) listed?
Transchem Ltd trades as TRANSCHEMLTD on the NSE and under code 500422 on the BSE.
Which sector does Transchem Ltd belong to?
Transchem Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Transchem Ltd?
Transchem Ltd has a market capitalisation of ₹467.6 Cr, which places it in the Small Cap band.
What is the PE ratio of Transchem Ltd?
Transchem Ltd trades at a PE ratio of 69.10, on earnings per share of ₹4.1, against a book value of ₹68.28 per share.
What is the 52-week high and low of Transchem Ltd?
Over the last 52 weeks Transchem Ltd has traded between ₹47.52 and ₹384.
What is the Return on Equity (ROE) of Transchem Ltd?
Transchem Ltd reported a return on equity of 5.14%. Its debt-to-equity ratio is 0.00.
Company Information
Transchem Ltd has transitioned from mushroom manufacturing and exports to financial services. After selling its non-operational Pune mushroom undertaking in 2020, it primarily earned through inter-corporate deposits and treasury investments.[1][2]
Website transchem.net
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/500422.md for Transchem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.